LianBio
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2020	12/31/2021	12/31/2022	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$0 N/A	$0 0%	$0 0%	Avg: $13.95M Low: $13.95M High: $13.95M avg. 0%	Avg: $107.8M Low: $107.8M High: $107.8M avg. 672.48%	Avg: $264.12M Low: $264.12M High: $264.12M avg. 145.00%
Net Income % change YoY	$-139.60M N/A	$-196.3M -40.61%	$-110.29M 43.81%	Avg: $-45.2M Low: $-45.32M High: $-45.32M avg. 59.01%	Avg: $-53.2M Low: $-52.88M High: $-52.88M avg. -17.69%	Avg: $52.88M Low: $52.88M High: $52.88M avg. 199.40%
EBITDA % change YoY	$-134.79M N/A	$-195.57M -45.08%	$-125.35M 35.90%	Avg: $0 Low: $0 High: $0 avg. 100%	Avg: $0 Low: $0 High: $0 avg. 0%	Avg: $0 Low: $0 High: $0 avg. 0%
EPS % change YoY	-$1.33 N/A	-$5.71 -329.32%	-$1.02 82.13%	Avg: -$0.42 Low: -$0.42 High: -$0.42 avg. 58.82%	Avg: -$0.49 Low: -$0.49 High: -$0.49 avg. -16.66%	Avg: $0.49 Low: $0.49 High: $0.49 avg. 200%
Operating Expenses % change YoY	$134.86M N/A	$195.57M 45.00%	$125.35M -35.90%	Avg: $0 Low: $0 High: $0 avg. -100%	Avg: $0 Low: $0 High: $0 avg. 0%	Avg: $0 Low: $0 High: $0 avg. 0%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 80.24% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -45.32M, average is -45.2M and high is -45.32M.

Wall Street analysts forecast annual average revenue growth of 272.49% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $13.95M, average is $13.95M and high is $13.95M.

Wall Street analysts forecast annual average earnings growth of 80.71% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.42, average is -$0.42 and high is $-0.42.